Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Aethlon Medical (AEMD) Operating Expenses (2016 - 2025)

Aethlon Medical (AEMD) has disclosed Operating Expenses for 15 consecutive years, with $2.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Operating Expenses fell 19.39% year-over-year to $2.0 million, compared with a TTM value of $9.3 million through Mar 2025, down 26.08%, and an annual FY2025 reading of $9.3 million, down 26.08% over the prior year.
  • Operating Expenses was $2.0 million for Q1 2025 at Aethlon Medical, up from $1.8 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $3.8 million in Q1 2022 and bottomed at $1.8 million in Q4 2024.
  • Average Operating Expenses over 5 years is $2.8 million, with a median of $2.8 million recorded in 2022.
  • The sharpest move saw Operating Expenses soared 71.21% in 2022, then plummeted 49.1% in 2024.
  • Year by year, Operating Expenses stood at $2.5 million in 2021, then rose by 11.97% to $2.8 million in 2022, then increased by 25.17% to $3.6 million in 2023, then plummeted by 49.1% to $1.8 million in 2024, then increased by 10.38% to $2.0 million in 2025.
  • Business Quant data shows Operating Expenses for AEMD at $2.0 million in Q1 2025, $1.8 million in Q4 2024, and $2.9 million in Q3 2024.